Spire Wealth Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Spire Wealth Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100	Closed	-$2.41K	–	2572
2023 Q1	$2.41K	Hold	100	–	–	﹤0.01%	2224
2022 Q4	$1K	Buy	+100	New	+$807	﹤0.01%	2288

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Spire Wealth Management's PRVB Position: Q2 2023 in Review

Spire Wealth Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 100 shares — an estimated $2.41K sold.

Spire Wealth Management first reported a position in PRVB in Q4 2022 and held it in 2 quarters. The position peaked at $2.41K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Spire Wealth Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Spire Wealth Management sold 100 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $2.41K.
Spire Wealth Management first reported a position in Provention Bio, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Spire Wealth Management's Provention Bio, Inc. Common Stock position peaked at $2.41K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Spire Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.